REAL-WORLD EPIDEMIOLOGICAL EVIDENCE COLLABORATION AGREEMENTCollaboration Agreement • February 7th, 2021
Contract Type FiledFebruary 7th, 2021dated as of January 6, 2021 (this “Agreement”) by and between the Israeli Ministry of Health, acting on its own behalf and on behalf of the State of Israel (the “MoH”), and Pfizer Inc., a Delaware corporation (together with its Affiliates, “PFIZER”) (each, a “Party” and, collectively, the “Parties”).
REAL-WORLD EPIDEMIOLOGICAL EVIDENCE COLLABORATION AGREEMENTCollaboration Agreement • January 12th, 2021
Contract Type FiledJanuary 12th, 2021dated as of January 6, 2021 (this “Agreement”) by and between the Israeli Ministry of Health, acting on its own behalf and on behalf of the State of Israel (the “MoH”), and Pfizer Inc., a Delaware corporation (together with its Affiliates, “PFIZER”) (each, a “Party” and, collectively, the “Parties”).
REAL-WORLD EPIDEMIOLOGICAL EVIDENCE COLLABORATION AGREEMENTCollaboration Agreement • January 12th, 2021
Contract Type FiledJanuary 12th, 2021dated as of January 6, 2021 (this “Agreement”) by and between the Israeli Ministry of Health, acting on its own behalf and on behalf of the State of Israel (the “MoH”), and Pfizer Inc., a Delaware corporation (together with its Affiliates, “PFIZER”) (each, a “Party” and, collectively, the “Parties”).
REAL-WORLD EPIDEMIOLOGICAL EVIDENCE COLLABORATION AGREEMENTCollaboration Agreement • January 12th, 2021
Contract Type FiledJanuary 12th, 2021dated as of January 6, 2021 (this “Agreement”) by and between the Israeli Ministry of Health, acting on its own behalf and on behalf of the State of Israel (the “MoH”), and Pfizer Inc., a Delaware corporation (together with its Affiliates, “PFIZER”) (each, a “Party” and, collectively, the “Parties”).